Erin Newman

Erin has over 20 years of experience working in clinical research supporting drug and device development from pre-IND through FDA approval.  Erin joined Alkahest following 9 years as a consultant with Actelion/Cotherix where she was responsible for various project management and clinical operation functions within pulmonary and oncology indications.  Prior to that, she consulted for Zogenix and was responsible for conducting the registrational trials and supporting regulatory submissions for an approved drug-device combination therapy.  Additionally, she served as a consultant for Scios, Allergan and various CROs in cardiology, neurology and ophthalmology. Erin earned a BS in microbiology, with an emphasis in genetic engineering, from the University of California at Santa Barbara.